Literature DB >> 17330248

A two-part model for censored medical cost data.

Lu Tian1, Jie Huang.   

Abstract

The two-part model is often used to analyse medical cost data which contain a large proportion of zero cost and are highly skewed with some large costs. The total medical costs over a period of time are often censored due to incomplete follow-up, making the analysis difficult as the censoring can be informative. We propose to apply the inverse probability weighting method on a two-part model to analyse right-censored cumulative medical costs with informative censoring. We also introduce a set of simple functionals based on the intermediate cost history to be applied with the efficiency augmentation technique. In addition, we propose a practical model-checking technique based on the cumulative residuals. Simulation studies are conducted to evaluate the finite sample performance of the proposed method. We use a data set on the cardiovascular disease (CVD)-related Medicare costs to illustrate our proposed method.

Entities:  

Mesh:

Year:  2007        PMID: 17330248     DOI: 10.1002/sim.2847

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  7 in total

1.  Direct medical costs of constipation from childhood to early adulthood: a population-based birth cohort study.

Authors:  Rok Seon Choung; Nilay D Shah; Denesh Chitkara; Megan E Branda; Miranda A Van Tilburg; William E Whitehead; Slavica K Katusic; G Richard Locke; Nicholas J Talley
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-01       Impact factor: 2.839

2.  Longitudinal direct medical costs associated with constipation in women.

Authors:  R S Choung; M E Branda; D Chitkara; N D Shah; S K Katusic; G R Locke; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2010-11-22       Impact factor: 8.171

3.  A two-part model for reference curve estimation subject to a limit of detection.

Authors:  Z Zhang; O Y Addo; J H Himes; M L Hediger; P S Albert; A L Gollenberg; P A Lee; G M Buck Louis
Journal:  Stat Med       Date:  2011-01-25       Impact factor: 2.373

4.  Lifetime costs of medical care after heart failure diagnosis.

Authors:  Shannon M Dunlay; Nilay D Shah; Qian Shi; Bruce Morlan; Holly VanHouten; Kirsten Hall Long; Véronique L Roger
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-12-07

5.  EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT.

Authors:  Elizabeth A Handorf; Justin E Bekelman; Daniel F Heitjan; Nandita Mitra
Journal:  Ann Appl Stat       Date:  2013       Impact factor: 2.083

6.  Propensity score and doubly robust methods for estimating the effect of treatment on censored cost.

Authors:  Jiaqi Li; Elizabeth Handorf; Justin Bekelman; Nandita Mitra
Journal:  Stat Med       Date:  2015-12-17       Impact factor: 2.373

7.  Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry.

Authors:  Eva Pagano; Alessio Petrelli; Roberta Picariello; Franco Merletti; Roberto Gnavi; Graziella Bruno
Journal:  BMC Health Serv Res       Date:  2015-12-30       Impact factor: 2.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.